DIA
Drug Information Association Logo

Validation of Next Generation Sequencing Panels for Targetable Mutations in NSCLC and TNBC Using FFPEs and Liquid Biopsies.

Time

Tue, Jun 17 7:15AM
T 17

Title

Validation of Next Generation Sequencing Panels for Targetable Mutations in NSCLC and TNBC Using FFPEs and Liquid Biopsies.

Abstract Summary

Validation was conducted using a compartmentalized approach that validated the instrument, nucleic acid extraction, assay protocol, and bioinformatics as separate entities. NGS panels were run on the Illumina miSeq instrument. A minimum of 32 specimens were tested in replicate sequencing runs.

Poster Presenter

Rachel Skelton
Insight Genetics Inc.
United States